|
인쇄하기
취소
|
Daewoong to enter the major psychotic markets
Published: 2005-08-29 06:56:00
Updated: 2005-08-29 06:56:00
Daewoong (CEO: Yoon Jae-seung) announced to launch Spendalin (Risperidone) 2mg tablet, a drug for schizophrenia in the middle of Aug. aiming at an active entry of major psychotic drug markets.
Spendalin (Risperidone) improves a positive and negative symptom of mental disorders by blocking both of dopamine and serotonin receptors, showing less adverse reactions and recurrence compared to Halo...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.